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BACKGROUND

Results

Total Hip Arthroplasty (THA) is a common intervention for patients
with hip osteoarthritis (OA) who have failed conservative

92/101 (91%) of patients reported significant pain relief and
improvement in function 6 weeks after THA on subjective
reporting during their follow up visit. 9 patients reported no relief
from their surgery. No demographic differences reached
statistical significance aside from BMI which was 30.9 in the
group with good outcomes, and 31.9 in those without relief.

management. The prevalence of these procedures has been on the
rise over the last 2 decades, increasing >50% from 1995-2005, and
projected to increase ~150% from 2005 to 2030. (Otten) These
trends are likely due to an aging population, an increase in obesity,
better long-term outcomes of the procedure, and a more active
lifestyle of the elderly population. (Otten). Although the overall

DISCUSSION

successful procedure rate is high, 10-15% of patients are not
satisfied with their outcomes. (Hofstede). This leaves thousands of
patients dissatisfied with their outcomes every year. The longevity of
these prosthesis are limited as well, with revisions having worse
outcomes than primary THA. (Hofstede) This leads to the need for
better predictive outcomes for patients undergoing the procedure.

Figure 1
Preferred hip injection technique under ultrasound

BMI has long been a good predictor of outcomes, with higher BMI
correlating with worse outcomes, however, there has not been many
other predictive factors identified. Recent systematic reviews have
urged further research to find factors that can be predictive for THA.
Most guidelines state indications for THA as failure of
conservative

treatment

but

do

not

specifically

identify

hip

Table 1
First nationwide prevalence study of hip arthroplasty (2010)

Our study had many limitations including but not limited to, 1. No
control group of patients who did not receive a hip CSI prior to
THA. 2. The retrospective nature allowed only for subjective
response from patients in terms of good outcomes without the
use of a standardized scale. 3. Short-term follow up only of 6
weeks. Strengths of our study include clear documentation of
patients' responses to injection and surgery, as well as the
multicenter nature of the study. Our study’s hypothesis was a
positive correlation for patients receiving a hip CSI prior to THA
and good THA outcomes.

corticosteroid injections as part of this grouping. (AAOS). Most
studies do not identify this intervention as part of the failed

CONCLUSION

conservative treatment for patients as well. Our study looks to

This study is the first to the authors knowledge to

identify if relief following an intra-articular hip corticosteroid injection

evaluate if receiving an intra-articular hip CSI can be a

for OA is an indicator for relief following THA.

good predictor of THA outcomes. Our study showed

there may be a correlation between patients receiving
benefit from a hip CSI prior to THA. Further studies are
needed to look into this as a predictor of THA

METHODS

outcomes.

This study was a multi-center, retrospective review of patients treated
within the Medstar-Georgetown health system, as well as the
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